The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Sean Laaman is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/28/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/07/2025 | ALEC | Buy Now | Alector | $1.33 | 12.78% | Sean Laaman73% | $3 → $1.5 | Assumes | → Underweight | Get Alert |
| 12/03/2024 | BGNE | Buy Now | BeiGene | — | — | Sean Laaman73% | → $300 | Assumes | → Overweight | Get Alert |
| 10/27/2023 | RMD | Buy Now | ResMed | $221.47 | -23.69% | Sean Laaman73% | → $169 | Upgrade | Equal-Weight → Overweight | Get Alert |
